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Abstract
Extrapulmonary tuberculosis (TB) is a significant public health challenge in South Africa and worldwide,
largely fuelled by the HIV epidemic. In spinal TB, Mycobacteria infect the spinal column without dissemi-
nation to the spinal cord. The immune microenvironment, target cell characteristics, and other evolutionary
forces within granulomas during HIV/TB coinfection are poorly characterized. We investigated whether spinal
TB granulomas represent a sequestered anatomical site where independent HIV evolution occurs, and assessed
the role of macrophages as a target cell for both HIV and mycobacteria. RNA was extracted from plasma and
granulomatous tissue from six antiretroviral-naive HIV-1/spinal TB-coinfected patients, RT-PCR amplified,
and the C2-V5 env segment was cloned and sequenced. Analysis of genetic diversity, phylogeny and coales-
cence patterns was performed on clonal sequences. To investigate their role in HIV sequestration, macrophages
and the HIV-1 p24 protein were immune localized and ultrastructural features were studied. Intercompartment
diversity measurements and phylogenetic reconstruction revealed anatomically distinct monophyletic HIV-1
clusters in four of six patients. Genotypic CCR5-tropic variants were predominant (98.9%) with conservation of
putative N-linked glycosylation sites in both compartments. CD68+ reactivity was associated with higher tissue
viral load (r = 1.0; p< 0.01) but not greater intrapatient diversity (r= 0.60; p> 0.05). Ultrastructural imaging
revealed the presence of bacterial and virus-like particles within membrane-bound intracellular compartments
of macrophages. Spinal tuberculosis granulomas may form anatomically discreet sites of divergent viral evo-
lution. Macrophages in these granulomas harbored both pathogens, suggesting that they may facilitate the
process of viral sequestration within this compartment.
Introduction
One of the most devastating complications of theworldwide HIV-1/AIDS epidemic has been the dramatic
increase in the incidence of active tuberculosis (TB) at pul-
monary and extrapulmonary sites.1 HIV infection contributed
to 1.1 million new TB infections and approximately 320,000
TB-related deaths in 2012 alone; 75% of these occurred in
Africa.1 This enormous disease burden represents a serious
challenge to TB control programs in resource-constrained
1Africa Centre for Health and Population Studies, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal (UKZN),
Durban, South Africa.
2Department of Virology, Nelson R. Mandela School of Medicine, UKZN, Durban, South Africa.
3KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), UKZN, Durban, South Africa.
4Department of Orthopedics, Nelson R. Mandela School of Medicine, UKZN, Durban, South Africa.
5School of Public Health, Sefako Makgatho Health Sciences University, Medunsa, South Africa.
6Optics and Imaging Centre, Nelson R. Mandela School of Medicine, UKZN, Durban, South Africa.
7MRC Inflammation and Immunity Unit, Department of Immunology, University of Pretoria, Pretoria, South Africa.
8HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, UKZN, Durban, South
Africa.
9Max Planck Institute for Infection Biology, Chariteplatz, Berlin, Germany.
10The Ragon Institute of MGH, MIT and Harvard University, Cambridge, Massachusetts.
AIDS RESEARCH AND HUMAN RETROVIRUSES
Volume 32, Number 3, 2016
ª Mary Ann Liebert, Inc.
DOI: 10.1089/aid.2015.0189
262
regions where access to combination antiretroviral therapy
(ART) and large-scale antituberculosis prophylaxis is still
suboptimal and logistically challenging. HIV-1-induced im-
munodeficiency leads to increased risk of newly acquired TB
and adverse clinical outcomes.2 Furthermore, HIV replication,
diversity, persistence in tissue compartments and reservoirs
complicate clinical outcomes and pose a threat to therapeutic
management and cure strategies.3,4
HIV-1 diversity is a function of its error-prone reverse
transcriptase, replication rate, recombination, and host se-
lective pressures.5 Following transmission, HIV-1 spreads to
various anatomical sites where the site-specific microenvi-
ronment regulates its evolutionary kinetics.6,7 HIV-1 repli-
cation in remote or sequestered anatomical sites may have
clinical consequences by creating a source of virus for
transmission, drug resistance (due to poor drug penetration),
tissue-specific clinical deterioration, and establishment of
long-lived viral reservoirs.8,9 The role of coinfections such as
TB, and related immune and cellular microenvironment re-
modeling in promoting independent viral evolution at tissue
sites of infection, is poorly understood. We do know that
these sites have clinical relevance as they may prevent access
of infected cells to ART and appropriate host immune re-
sponses.3 Anatomical compartments representing discrete
sites of independent viral evolution include the central ner-
vous system, genital tract, kidney epithelium, and lymph
nodes.10–14 Whether the same is true within TB coinfected
granulomas is currently unclear and inconclusive.15–17 Un-
derstanding the dynamics of viral evolution within this un-
ique highly compartmentalized but immunologically active
environment is important to virus eradication strategies. The
nature of the viral variants, their response to treatment, and
the mechanisms that govern their progression to sequestra-
tion may play critical roles in clinical patient management.
The host immune response to TB is not fully characterized
but involves primarily macrophages and CD4+ and CD8+ T
cells.2,18 Histopathology studies of pulmonary and pleural
TB have been performed18 but exploratory investigations of
the spine are rare.19,20 None of these studies, however, fully
explores the role of specific cell types, such as macrophages,
as drivers and/or sites of divergent HIV evolution.
In this study we sought to investigate whether the extra-
dural spinal TB granuloma formed an anatomical site of HIV
sequestration by analyzing clonal sequences generated from
the blood and spinal granuloma biopsies of coinfected pa-
tients. Our investigation revealed evidence of divergent viral
evolution within spinal TB granulomas. We also explored the
immune microenvironment with specific focus on macro-
phages given that TB andHIV are intracellular pathogens that
target macrophages. Immunolocalization studies revealed the
presence of HIV-infected macrophages while electron mi-
croscopy provided evidence of HIV and TB particles within
an intracellular endosomal compartment.
Materials and Methods
Study subjects, clinical assessment,
and specimen collection
The Institutional Review Board of the University of
KwaZulu-Natal approved the study protocol (Ref. #H112/
02). All participants or their legal guardians provided in-
formed consent. Blood and matched granuloma tissue were
obtained from six HIV-1/spinal tuberculosis coinfected pa-
tients undergoing vertebral excision and anterior spinal de-
compression to resolve associated neurological deficits at
King George V Hospital (now King Dinuzulu Hospital) in
Durban, South Africa. Given that extrapulmonary TB with
HIV coinfection is AIDS defining (WHO stage 4) all patients
were classified accordingly. Cerebrospinal fluid (CSF) was not
sampled since there was no clinical justification to sample the
CSFgiven that theMycobacterium tuberculosis (Mtb) infection
had not disseminated and breached the blood–brain barrier.
All patients received preoperative nutritional support to achieve
safe hemoglobin and albumin levels (>100 g/liter and >300 g/
liter, respectively) and standard antituberculosis therapy
(600mg rifampicin, 400mg isoniazid, 1,500mg pyrazinamide,
1,500mg and 1,200mg ethambutol daily) for a mean period of
8 weeks (range= 5–24 weeks). All patients were antiretroviral
(ARV) drug naive since ART had not been rolled out as part of
the national policy at the time of sample collection.
The excised granulomatous tissue was processed imme-
diately for histology, bacterial culture diagnostics, and mo-
lecular assays. A venous blood sample was collected for
quantification of HIV-1 viral load (Nuclisens HIV-1 QT kit,
Organon Teknika) and T-lymphocyte subsets (Beckman
Coulter TetraOne method). For tissue viral load analysis
(Nuclisens HIV-1 QT kit), HIV RNA was extracted from
10mg of tissue. Tissue was weighed and then homogenized
in lysis buffer (Nuclisens isolation kit, Biomerieux) prior to
RNA extraction using the MiniMag Magnetic Extraction
protocol (Biomerieux) and HIV RNAwas quantified with the
Nuclisens HIV-1 QT Kit (Biomerieux). Viral loads were
expressed as cp/ml of blood for plasma samples and cp/mg of
tissue in the case of the granulomas.
Immunolocalization of CD68+/p24+ cells
CD68+ cells (macrophages/monocyte lineages; Clone
KP1, Dako; dilution 1:200) and HIVp24 antibody (Clone
Kal-1, Dako, Denmark; dilution 1:10) were immunolocalized
to 5-lm-thick sections of granulomatous tissue using an in-
direct immunoperoxide-staining protocol (Dako Envision
Dual Staining kit, Dako). Visualization and capture of posi-
tive staining cells utilized the Soft Imaging System (SIS). The
region of interest in each section at the same initial magni-
fication (·40) was selected based on typical features of a
granuloma, namely, a central core of necrosis containing
macrophages and multinucleated giant cells surrounded by
lymphocytes. Additional biopsies were fixed, processed, and
embedded using conventional techniques for transmission
electron microscopy (TEM). Ultrathin sections (50 nm) were
stained according to standard protocols and viewed with the
Jeol JEM-1011 transmission electron microscope and iTEM
imaging software.
PCR amplification and cloning
Paired plasma and tissue samples were available for se-
quencing for six patients (three adults, three children). HIV-1
RNA templates, extracted using the MiniMag extraction
protocol, were reverse transcribed (Superscript III reverse
transcriptase; Invitrogen, San Diego, CA) and a 621-bp seg-
ment of the env gene (7,026 to 7,647 by HXB2 numbering)
was amplified as previously described.21 Purified amplicons
(Qiagen, Valencia, CA) were cloned into the pCR2.1-TOPO
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TA vector (Invitrogen) and positive plasmids (5–10 clones)
were purified and sequenced (Big-Dye terminator V3.1).
Sequence editing, alignment, and analysis
All HIV-1 env choromatograms were imported into Gen-
eious v6 (www.geneious.com), visually edited, and accepted
for analysis if quality scores were >90%. To exclude potential
contamination, newly derived sequences were compared to
subtype reference strains (Los Alamos database; http://hiv-
web.lanl.gov/content/hiv-db/SUBTYPE_REF/align.html)
and to HIV-1 sequences previously amplified in our lab-
oratory. Consensus sequences generated in Geneious were
codon aligned in Clustal W22 and manually edited in SeAL
(http//:tree.bio.ed.ac.uk). Phylogenetic trees were con-
structed for the entire dataset against HIV-1 reference
sequences and for the plasma and granuloma sequences
from individual patients. Maximum likelihood (ML) and
Bayesian trees were reconstructed in RaxML23 and
MrBayes24 respectively using appropriate models esti-
mated in ModelTest25 and an estimated gamma hetero-
geneity alpha parameter. The ML tree topology was
optimized in RaxML and the reliability of the internal
nodes was estimated using 1,000 bootstrap replicates (ML
trees) or four Markov Chain Monte Carlo (MCMC) chains
with 106 generations and a 10% burning (Bayesian trees).
Results were visualized using Tracer parameters where an
effective sample size (ess) >200 suggested good mixing
and sampling of the trees. Consensus trees and posterior
support for internal nodes were generated in TreeAnnotator
(www.beast2.org/wiki/index.php/TreeAnnotator) and anno-
tated in FigTree (http://tree.bio.ed.ac.uk/software/figtree/).
Analysis to confirm viral compartmentalization
and migration
Assessment of viral compartmentalization was performed
using tree-based and diversity-based algorithms in DIVEIN
(http://indra.mullins.microbiol.washington.edu/DIVEIN/)
and HyPhy.26 We performed the intracompartment diversity
and the two-sample diversity tests (z-test and t-test) in
DIVEIN. In Hyphy we performed two tree-based tests of
compartmentalization: the Slatkin–Maddison (SM) test to
calculate the probability of as many or fewer migrations from
one compartment to the other occurring by chance, the branch
count correlation coefficient (rb), and the branch length
correlation (r). We also employed the distance-based Hudson
nearest-neighbor test (S-nn; TN93 model, 500 resampling).
All sequences were screened for signature patterns indicative
of viral tropism (CCR5 or CXCR4 usage) using the online
Geno2Pheno tool (www.geno2pheno.org/).27
Statistical analysis
All statistical analyses were undertaken in Stata v11. A 5%
( p < 0.05) level of significance was accepted for all analyses
unless otherwise stated.
Results
Clinical and demographic findings
All patients (n = 6) were diagnosed with active spinal TB
based on presumptive clinical and radiological findings.
Their demographic and clinical information are summarized
in Table 1. Data on when these patients acquired their HIV
infection were not available. Because patients did not present
with symptoms suggesting other viral infections related di-
agnostic tests were not performed. Since mycotic infections
of the spine have a clinical presentation similar to spinal TB,
patient samples were tested for evidence of fungal infection
and were found to be negative. Tissue viral loads were high
and well in excess of 5 log/mg in all patients. There was no
correlation between tissue and plasma viral load measure-
ments (Table 1).
Phylogenetic tree-based analysis of divergence
A total of 94 sequences, generated from tissue and plasma
(50 plasma-derived and 44 tissue-derived sequences) of six


















TB12 Female 2 21* 40* 4.2 8.1 No growth No neurology (Frankel E)
TB25 Female 3 23* 50* 4.3 ND No growth Spastic paraplegia
TB32 Male 2 12* 30* 6.4 9.2 Mtb Advanced AIDS; oral
thrush, enlarged and
inflamed lymph nodes
TB16 Male 28 ND ND 4.5 6.5 No growth Paraplegic; complete
immobility (Frankel
A); incontinent
TB20 Female 25 100 661 5.7 5.4 Mtb ND
TB38 Female 43 ND ND 4.9 8.2 Mtb ND
Mean – SD
(range)
Adults 32– 15.9 — — 5.0 – 0.5 6.7 – 1.1
Children 2.3 – 2.1 18.6 – 6.1* 40 – 16.2* 4.9 – 1.2 8.7 – 0.8
aCD4 and CD8 measurements for adults (‡16 years old) are presented as absolute values and for children (<16 years old) are presented as
percentages as indicated by an asterisk(*).
bClinical data are presented where available.
ND, no data available; Mtb, Mycobacterium tuberculosis.
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patients, were analyzed. Our objectives were first, to recon-
struct patient sequences in relation to reference sequences,
and second, to determine the clustering and gene flow pat-
terns of sequences derived from the two anatomic compart-
ments of individual patients. Phylogenetic reconstruction of
clonal and published HIV-1 reference sequences (Subtypes A
to K) confirmed that all patient sequences were HIV-1 sub-
type C (Fig. 1A). Tissue-derived and plasma-derived se-
quences from each patient clustered together, distinct from
those of other participants, indicating that there was no in-
terpatient contamination.
Phylogenetic reconstruction of individual patient se-
quences demonstrated two distinct clustering patterns, the
first of discrete monophyletic clusters of tissue-derived and
plasma-derived sequences, and the second of intermingling
(Fig. 1B–G). In four of six patients (Fig. 1B–E), plasma-
derived and tissue-derived sequences clustered in discrete
branches. The longer branch lengths observed, coupled with
high internal branch support (posterior probability scores
>0.9 and bootstrap values >80%), strongly suggested diver-
gent evolution within these compartments. Tree topologies
were suggestive of a founder effect where a single viral
variant entered and, over time, expanded into a unique
monophyletic cluster within spinal granulomas. In these four
cases, all computational tests of compartmentalization (SM,
R, r-b, Snn, and intracompartment distance) concurred with
statistical significance ( p < 0.01; Table 2 and Fig. 1B–E).
Together, these findings confirmed the separation of plasma-
derived and tissue-derived sequences into distinct mono-
phyletic populations in these patients (Fig. 1B–E).
The remaining two datasets, both from children <5 years of
age, illustrated the second clustering pattern where plasma-
derived and tissue-derived sequences were intermingled with
unrestrained migration of HIV-1 variants between compart-
ments (Fig. 1F and G). The tests of compartmentalization
for these two study participants (Table 2; Fig. 2E and F)
FIG. 1. (A) A maximum likelihood tree of clonal plasma (red) and tissue-derived (green) sequences from individual
patients clustering within the subtype C lineages (blue). Reference sequences of subtypes A ( pink), B ( purple), D (light
blue), F (dark green), G (black), H (orange), J (salmon), and K (yellow) are also represented. The phylogenetic recon-
struction was performed in RaxML using the HKY85 model with gamma distribution. (B–G) Phylogenetic reconstructions
illustrating maximum likelihood trees constructed in RaxML of individual patient plasma-derived (red) and tissue-derived
(green) sequences with branch support indicated are represented. (B–E) Two distinct patterns of clustering are observed
where monophyletic clustering is shown [(B) TB16; (C) TB20; (D) TB25; (E) TB38)] and intermixing of variants is
illustrated [(F) TB12 and (G) TB32]. The panels below each phylogenetic tree are graphic representations of in-
tracompartment diversity measures as estimated in DIVEIN, which illustrates the median diversity and IQR. Two-sample
diversity tests (T) were conducted and illustrated are p-values derived from z-tests and t-tests comparing intracompartment
diversity of plasma-derived with tissue-derived sequences.
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confirmed our visual observations in the phylogenetic trees;
we therefore concluded that there was intermixing in these
patients.
Analysis of viral tropism
Since key viral determinants of cell tropism and coreceptor
usage are located within the env V3 loop,28 we investigated
whether there were V3 loop amino acid differences between
plasma-derived and tissue-derived sequences (Table 2). The
biochemical properties (charge, size, hydrophobicity) at the
amino acid positions determining the folding patterns of the
V3 loop were similar and indicative of predominantly CCR5-
utilizing variants in plasma and tissue. Only two plasma se-
quences from TB20 differed, where a 2-amino acid insertion
resulted in a shift in putative coreceptor usage from CCR5 to
CXCR4 (Table 2).
Immunohistology and ultrastructural morphology
Macrophages play an important role, both as target cells
and mediators of the immune response, in HIV and TB dis-
ease pathogenesis. We therefore explored their possible role
in the complex host–pathogen interaction within the ana-
tomically remote spinal granuloma (Fig. 2A and B). While
the overall number of CD68+ cells infiltrating the granulo-
mas (indicated by the area of reactivity) was comparable, the
level of CD68 expression (indicated by the intensity of the
stain) differed and correlated with greater tissue viral load
(rho= 1.0; p< 0.01) and greater intrapatient genetic dis-
tance (rho = 0.60; p = 0.2; Fig. 2B). These results suggest that
increased site-specific macrophage activity is associated
with higher HIV replication rates and viral loads in spinal
TB-granulomas, although a causal relationship cannot be
established.
For three of the six patients enough tissue samples were
available for further IHC analysis of HIV and macrophage
colocalization. Analysis of CD68+ cells and HIV-1 p24 an-
tigen by immunohistochemistry within granulomas revealed
that in three of the six patients selected for sequence analysis
(TB12, TB 16, and TB 25) there was clear evidence of HIV
p24-CD68 colocalization (Fig. 2C), with two of these patients
(TB 16 and TB 25) possessing tissue-compartmentalized
viral sequences. Finally, our investigations of ultrastructural
features of coinfection and pathology revealed, under TEM,
bacterial (Fig. 2D) and virus-like particles (Fig. 2E) within
membrane-bound intracellular compartments in cells identi-
fied as macrophages.
Discussion
HIV-1-induced immune suppression has led to an increase
in disseminated mycobacterial infections worldwide. Ad-
ditionally, anatomical and cellular HIV reservoirs are of great
clinical interest because they may impact pathogenesis,
ART-mediated virus suppression, or strategies for HIV
eradication.29 In this study we investigated the impact of
anatomic sequestration of HIV, within a tuberculous spinal,
granuloma on viral evolution. Using phylogenetic recon-
struction and computational measures of compartmentaliza-
tion30 we provide the first evidence to suggest divergent HIV
evolution in spinal TB coinfected granulomas. These findings
were supported by the fact that we noted no correlation be-
tween tissue and plasma viral load measurements, which
suggests that viral variants in the tissue either accumulated
slowly over time independent of plasma populations or are
undergoing rapid tissue-specific expansion. We further
demonstrated a possible role of macrophages as an intracel-
lular compartment for viral sequestration and divergent
evolution at the site of coinfection.
Our findings parallel those of Collins et al.15 that demon-
strated divergent HIV evolution in pleural TB granulomas. In
both instances, physical separation appears to promote viral
Table 2. Summary of Tests of Compartmentalization Comprising Tree-Based (*)
and Diversity-Based (#) Algorithms


















TB12 0.008 – 0.001 0.006 – 0.001 0.29; 0.30 43 1025 0.002 0.002 0.262 9 (100) 9 (100)
TB25 0.002 – 0.001 0.017 – 0.002 9.93 1027;
1.023 1026
6.73 1025 0.002 0.002 0.000 8 (100) 8 (100)
TB32 0.002 – 0.0002 0.040 – 0.012 0.46; 0.46 0.022 0.002 0.03 0.000 9 (100) 4 (100)
TB16 0.002 – 0.0002 0.008 – 0.001 0.02; 0.02 0.0005 0.002 0.002 0.000 6 (100) 9 (100)
TB20 0.058 – 0.003 0.002 – 0.001 0.00; 0.29 0.0003 0.002 0.002 0.000 6 (77) 9 (100)
TB38 0.052 – 0.008 0.005 – 0.001 0.006; 0.09 0.001 0.004 0.002 0.000 6 (100) 7 (100)
aIntracompartment pairwise distance (DIVEIN).
bSlatkin–Maddison test (HyPhy).
cBranch length correlation coefficient (r, HyPhy).
dBranch count correlation coefficient (rb; HyPhy).
eHudson nearest neighbor (Snn; HyPhy).
fCoreceptor usage is indicated as percentage number of sequences.
gCoreceptor usage potential was analyzed using the online tool Geno2Pheno (www.geno2pheno.org) that uses sequence data and support
vector machine (SVM) classifiers to predict coreceptor usage.
Tests of compartmentalization were executed in DIVEIN and HyPhy software packages indicating statistical support for divergence and
anatomical compartmentalization.
Statistical significance is indicated by p values where values <0.05 are underlined and <0.005 appear in bold.
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evolution within TB-infected tissue. Unlike pulmonary tissue
where migration of immune cells, both HIV infected and
uninfected, is continuous,17 the influx of immune cells to the
spinal tissue is unlikely to have preceded TB infection. An
influx of HIV-infected immune cells and free virions would
explain the evidence of a ‘‘founder effect’’ that we observed
through phylogenetic reconstruction. Furthermore, the close
contact between HIV-infected lymphocytes and TB-infected
macrophages may facilitate enhanced HIV replication or
even cell-to-cell HIV spread.31 Despite high tissue viral
loads, intracompartment diversity was low, consistent with
the hypothesis of clonal expansion of HIV variants from a
founder virus that migrated into the spinal TB granuloma.
Furthermore, we showed greater viral diversity and evolu-
tionary distance between plasma-derived and tissue-derived
viruses, particularly when comparing adults with children;
this is a reflection perhaps of the immature immune systems
of children or more recent HIV acquisition where lower di-
versity is a characteristic of recent infection and early viral
kinetics.
The immune response and physiology of children differ
significantly from adults; however, our findings suggest that
the phenomenon of viral sequestration within spinal TB
granulomas may not be impacted by the age of the patient but
may be influenced by the duration of infection. We do not
know the precise timing of infection of either the adults or
children but we speculate that adults may on average have
been infected longer considering that disease progression is
accelerated in children compared with adults32 and the ad-
vanced clinical disease (low CD4 and high VL) among adults
in this cohort.
HIV population dynamics follow a strong temporal struc-
ture where sequences from samples taken from an individ-
ual at the same time point cluster together.12 It may be
argued that a similar phenomenon is reflected in our findings
of monophyletic clustering. However, the tree topologies
and longer branch lengths we observed may equally be in-
dicative of the impact of complex phylodynamic determi-
nants such as immune selection pressure and site-specific
population dynamics between latent/reactivated and pro-
ductive viremia. Moreover, we demonstrated migration
from the tissue to the plasma in two of six patients, both
children (<5 years of age), suggesting that the contribution
to the systemic viral population from the tissue may be
limited. In contrast, Collins et al.15 noted frequent, unidi-
rectional migration events from pleura to blood represen-
tative of a direct mechanism for greater systemic HIV
heterogeneity.
FIG. 2. (A) A micrograph image of a typical granuloma illustrating the region of interest used for our analysis of CD68
immunolocalization (initial magnification, ·40). CD68-positive cells appear in pink and nuclei in blue. This image illus-
trates a typical granuloma with positively stained ( pink) macrophages counted for semiquantitative analyses of intensity and
area of immunolocalization. (B) A graphic illustration of the association (rho= 0.6; p > 0.05; 95% CI) between the area of
CD68 immunoreactivity and the overall mean intrapatient genetic distance of plasma-derived and tissue-derived sequences.
(C) A light micrograph and (D, E) transmission electron micrographs (TEM) of the spinal TB granulomas. Localization of
macrophages ( pink) and HIV p24 (black) appear in (C) (initial magnification ·40) with colocalized CD68+/p24+ within the
same cells indicated by an arrow. (D) A TEM showing a bacterial cell (arrowhead) within an intracellular membrane-bound
compartment. (E) Virus particles (arrows) were also observed, under TEM, within a similar membrane-bound intracellular
compartment of a cell displaying macrophage morphology [(D, E) initial magnification ·50].
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The role of the V3 loop in viral tropism, cytopathi-
city, replication efficiency, and fusion is known.28 CCR5
exploiting variants predominate, even in the context of My-
cobacteria coinfections.33 Our findings established CCR5-
utilizing variants in both plasma and tissue in all but two
sequences; this is consistent with previous studies of HIV-1
subtype C infections showing minimal corrector switch from
CCR5 to CXCR4 even in the context of late stage AIDS and
coinfections such as pulmonary TB.28 Phenotypic studies
may be warranted since genotype does not always accurately
predict coreceptor utilization and subtle differences in usage
of CD4 and coreceptors have been noted with CSF-derived
and other viral isolates.34,35
Given the prominent role of macrophages in the anti-TB
immune response we explored their composition in the
granulomas and found evidence of HIV-infected macro-
phages. In this study, we present electronmicrographs of both
HIV and TB within membrane-bound intracellular com-
partments. To the best of our knowledge, this is the first
reported evidence of viral particles in endosomal com-
partments in spinal TB/HIV-coinfected tissue. We further
demonstrated an association between viral diversity and
macrophage infiltration of spinal granulomas suggesting that
macrophages may be a possible cellular target of HIV in-
fection in granulomas. This hypothesis is plausible for four
reasons: (1) macrophages show susceptibility to HIV in-
fection, (2) infiltration of differentiated immune cells to the
site of infection, (3) long-lived archived viruses demon-
strated within macrophages, and (4) SIV models showing
HIV infection of monocytes and macrophages. In the first
instance, susceptibility to HIV infection is increased in
differentiated macrophages, which are abundant in TB
granulomas, compared to undifferentiated monocyte-
derived macrophages (MDM).36 Second, the influx of ac-
tivated immune cells including differentiated macrophages
to the site of infection regardless of HIV status and the
concomitant HIV-related T cell depletion19 mean that an
environment permissive to exploiting macrophages may be
created in spinal TB granulomas. However, there remains
controversy around this paradigm with conflicting reports
showing that CD4 depletion either has an impact37 or has no
impact38 on HIV infection of myeloid cells. Third, long-
lived HIV lineages have previously been correlated with
macrophage-targeting HIV variants in the CNS.7,35 Finally,
it is noteworthy that myeloid cells (macrophages, mono-
cytes, and dendritic cells) have been shown to become in-
fected with HIV following phagocytosis of infected T cells
in the SIV model of infection.38
A limitation of our study is the small sample size and the
limited number of clones analyzed per compartment. The
challenges in amplifying the HIV genome from tissue re-
stricted our use of limiting dilution techniques such as single
genome amplification, which have been shown to mitigate
the problem of variant resampling within quasispecies.39–41
However, it has also been demonstrated that the problems of
variant resampling, population structure differences, and
sequencing bias can be overcome or reduced if a large enough
number of clones is analyzed.42 Although we analyzed only
an average of seven clones per compartment in our study, we
employed rigorous quality checks at both the laboratory and
analysis stages of our study to ensure that we did not con-
found the interpretation of viral population diversity. In this
study, we did not explore the contribution of the CSF-derived
variants to the viral population within these granulomas. In
our study and previous clinical case reports it was shown that
Mtb infection of the spine is extradural both in HIV-infected
and HIV-uninfected patients43 and penetration of the me-
ninges into the spinal cord is rare,44 thus maintaining the
integrity of the blood–brain barrier. The possibility of viral
trafficking between the granuloma and the CSF site cannot be
ruled out, and this aspect needs to be explored in future in-
vestigations. Investigating the spinal granuloma as a site of
HIV divergence also requires investigation of viral diver-
gence in the context of ART, which we were unable to ex-
plore in the present study. Future prospective investigations
will include HIV-infected patients on ART.
Conclusions
We show, in this small study, that spinal granulomas may
form a site of independent viral evolution. If confirmed in
larger studies, this may have implications for viral suppres-
sion and eradication strategies in sequestered sites based on
whether antiretroviral therapy can penetrate these sites. We
also show the possible involvement of macrophages in HIV
replication within granulomas and raise the intriguing ques-
tion of whether HIV exploits the survival strategies of TB to
sequester within macrophages. Further studies to confirm
these findings and to explore the accessibility of this ana-
tomical niche by antiretroviral drugs and its implications for
clinical disease progression, treatment, and eradication
strategies are warranted.
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